| 000 | 01472 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517115556.0 | ||
| 264 | 0 | _c20170922 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1435-5922 | ||
| 024 | 7 |
_a10.1007/s00535-016-1266-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartelli, Laura | |
| 245 | 0 | 0 |
_aCost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology _cJan 2017 |
||
| 300 |
_a19-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Monitoring _xeconomics |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aOlivera, Pablo | |
| 700 | 1 | _aRoblin, Xavier | |
| 700 | 1 | _aAttar, Alain | |
| 700 | 1 | _aPeyrin-Biroulet, Laurent | |
| 773 | 0 |
_tJournal of gastroenterology _gvol. 52 _gno. 1 _gp. 19-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00535-016-1266-1 _zAvailable from publisher's website |
| 999 |
_c26451234 _d26451234 |
||